Conditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancer.

Ovarian cancer remains difficult to treat mainly due to presentation of the disease at an advanced stage. Conditionally-replicating adenoviruses (CRAds) are promising anti-cancer agents that selectively kill the tumor cells. The present study evaluated the efficacy of a novel CRAd (Ad5/3-CXCR4-TIMP2...

Full description

Bibliographic Details
Main Authors: Sherry W Yang, Diptiman Chanda, James J Cody, Angel A Rivera, Reinhard Waehler, Gene P Siegal, Joanne T Douglas, Selvarangan Ponnazhagan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3192051?pdf=render

Similar Items